An Atypical Withdrawal Syndrome in Neonates Prenatally Exposed to Gabapentin and Opioids

Journal of Pediatrics

Volumn 181, Issue , 2017, Pages 286-288

  Loudin, Sean ^a   Murray, Sara ^b   Prunty, Leesa ^c   Davies, Todd ^a   Evans, Joseph ^a   Werthammer, Joseph ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Cabell Huntington Hospital   (United States)

^c MARSHALL UNIVERSITY   (United States)

Author keywords

co exposure; gabapentin; NAS; neonatology; opioids; withdrawal

Indexed keywords

CLONIDINE; DIAMORPHINE; GABAPENTIN; HYDROMORPHONE; METHADONE; OPIATE; 4 AMINOBUTYRIC ACID; AMINE; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; NARCOTIC ANALGESIC AGENT;

ARTICLE; BEHAVIOR CHANGE; CLINICAL ARTICLE; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; ELECTROENCEPHALOGRAM; EYE MOVEMENT; GESTATIONAL AGE; HEPATITIS C; HUMAN; NEONATAL ABSTINENCE SYNDROME; NEWBORN; PRENATAL EXPOSURE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UMBILICAL CORD; EPIDEMIOLOGY; FEMALE; INFANT; PREGNANCY;

AMINES; ANALGESICS, OPIOID; CYCLOHEXANECARBOXYLIC ACIDS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; INFANT; INFANT, NEWBORN; METHADONE; NEONATAL ABSTINENCE SYNDROME; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RETROSPECTIVE STUDIES;

EID: 85007155105     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2016.11.004     Document Type: Article

References (14)

1. 1 Patrick, S.W., Schumacher, R.E., Benneyworth, B.D., Krans, E.E., McAllister, J.M., Davis, M.M., Neonatal abstinence syndrome and associated health care expenditures: United States, 2002-2009. JAMA 307 (2012), 1934–1940.
2. 2 Patrick, S.W., Davis, M.M., Lehman, C.U., Cooper, W.O., Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009-2012. J Perinatol, 35, 2015, 667.
3. 3 Tolia, V.N., Patrick, S.W., Bennett, M.M., Murthy, K., Sousa, J., Smith, P.B., et al. Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs. N Engl J Med 372 (2015), 2118–2126.
4. 4 Baird, C.R., Fox, P., Colvin, L.A., Gabapentin abuse in order to potentiate the effect of methadone: a survey among substance misusers. Eur Addict Res 20 (2014), 115–118.
5. 5 Bastiaens, L., Galus, J., Mazur, C., Abuse of gabapentin is associated with opioid addiction. Psychiatr Q, 2016, 10.1007/s11126-016-9421-7.
6. 6 Mersfelder, T.L., Nichols, W.H., Gabapentin: abuse, dependence, and withdrawal. Ann Pharmacother 50 (2016), 229–233.
7. 7 Sills, G.J., The mechanisms of action of gabapentin and pregabalin. Curr Opin Pharmacol 6 (2006), 108–113.
8. 8 Ohman, I., Vitols, S., Tomson, T., Pharmacokinetics of gabapentin during delivery, in the neonatal period, and lactation: does a fetal accumulation occur during pregnancy?. Epilepsia 46 (2005), 1621–1624.
9. 9 Wilens, T., Zulauf, C., Ryland, D., Carrellas, N., Catalina-Wellington, I., Prescription medication misuse among opioid dependent patients seeking inpatient detoxification. Am J Addict 24 (2015), 173–177.
10. 10 Rocha, L., Ondarza-Rovira, R., Maidment, N.T., Gabapentin modifies extracellular opioid peptide content in amygdala: a microdialysis study. Epilepsy Res 35 (1999), 13–20.
11. 11 Koob, G.F., Volkow, N.D., Neurociruitry of addiction. Neuropsychopharmacology 35 (2010), 217–238.
12. 12 Bao, Y.H., Zhou, Q.H., Chen, R., Xu, H., Zeng, L., Zhang, X., et al. Gabapentin attenuates morphine tolerance through interleukin-10. Neuroreport 25 (2014), 71–76.
13. 13 Montouris, G., Gabapentin exposure in human pregnancy: results from the Gabapentin Pregnancy Registry. Epilepsy Behav 4 (2003), 310–317.
14. 14 Carrasco, M., Rao, S.G., Bearer, C.F., Sundararajas, S., Neonatal gabapentin withdrawal syndrome. Pediatr Neurol 53 (2015), 445–447.